Template:Acute spinal cord injury treatment
Revision as of 19:58, 27 October 2020 by Rossdonaldson1 (talk | contribs) (→Acute Management of Spinal Cord Injury)
Acute Management of Spinal Cord Injury
- Neurogenic shock management
- Consider intubation injuries at C5 or above
- Consider surgical intervention for:
- Progressive neurologic deficits
- Unstable spine fractures
- Steroids are no longer recommended
Administration of methylprednisolone (MP) for the treatment of acute spinal cord injury (SCI) is not recommended. Clinicians considering MP therapy should bear in mind that the drug is NOT approved by the FDA for this indication. There is no Class I or Class II medical evidence supporting the clinical benefit of MP in the treatment of acute SCI. Scattered reports of Class III evidence claim inconsistent effects likely related to random chance or selection bias. However, Class I, II, and III evidence exists that high-dose steroids are associated with harmful side effects including death.
[1]- See EBQ:High Dose Steroids in Cord Injury for further discussion
- ↑ Hurlbert RJ et al. Pharmacological therapy for acute spinal cord injury. Neurosurgery. 2013 Mar;72 Suppl 2:93-105 http://www.ncbi.nlm.nih.gov/pubmed/23417182
